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INTRODUCTION 
Cesarean section (CSEC) is one of the most common surgical 
procedures performed in the both developed and developing 
countries [1]. Caesarean delivery in the United States accounts for 
32% of all births [2]. In 2017, CSEC in the European Union (EU) 
was performed at least 1.4 million times. Among the EU Mem-
ber States, caesareans were most frequent in Cyprus (54.8 %), 
Romania (44.1%), Bulgaria (43.1%), Poland (39.3%) and 
Hungary (37.3%) [3]. Similarly, high CSEC rates have been 
reported in the Australia and China, where 32.4% and 41% 
of births are by CSEC, respectively [4, 5]. CSEC in Ukraine 
accounts for up to 23% of all births.
As with any surgery, CSEC can be associated with surgical 
site infections (SSIs). Postpartum SSI after CSEC is a major 
cause of long hospital stays and there is an increased cost 
burden on the public healthcare systems as well as to mothers 
and their families [6, 7]. These infections are associated with 
high morbidity and mortality [8, 9] in women. Over the past 
two decades, along with significant improvements in clinical 
obstetric care in many countries, the incidence rate of SSIs 
after CSEC remains an important issue. 
Current guidelines for management of SSI recommend the use 
of antibiotics as well for prevention, and as for both treatment 
postoperative infections. However, the growing antimicrobial re-
sistance is limiting their use. Resistant SSI is becoming more and 
more pressing for medical specialists a worldwide. In the available 
literature, studies on antimicrobial resistance of infectious agents 
of SSIs after CSEC are limited. Monitoring of the prevalence of 
etiologic agents of SSIs after CSEC and antimicrobial resistance 
is necessary to enhance our knowledge of its epidemiology.
There is no surveillance system for SSI in Ukraine. Conse-
quently, incidence rates of SSI after CSEC and antimicrobial 
resistance in Ukraine are currently unknown. This creates 
problems as well for physicians and as infection control pro-
fessionals in Ukraine. To our knowledge, the prevalence of and 
causative agents of most SSIs among female in-patients have 
not been studies in Ukraine. This was the basis for our study.
THE AIM
The aim of this study was to obtain the first national esti-
mates of the current prevalence rate of SSI after CSEC and 
antimicrobial resistance of causing pathogens in Ukraine.
MATERIALS AND METHODS 
SETTING AND PARTICIPANTS
We performed a retrospective multicentre cohort study was 
based on surveillance data of SSI after CSEC in women’s from 
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January 1st, 2017 to December 31st, 2019 in 11 regional 
(tertiary) women hospitals of Ukraine. The hospitals had 
1850 beds. They are similar in terms of medical equipment, 
staff and number of beds. Women hospitals were required to 
have at least one full-time infection-control professional and 
clinical microbiology laboratory. Only hospitals that provid-
ed data using the same surveillance option (patient-based) 
for at least three years were included in the study.
The study population included 2,326 women aged 20-51 
years who underwent cesarean delivery from 2017 to 2019 
in 11 regional women hospitals in Ukraine. All women who 
underwent caesarean section within the 30 day follow-up 
period met the inclusion criteria and were included in the 
study cohort. All participants were local residents. 
DEFINITIONS AND DATA COLLECTION
Diagnosis of SSIs after CSEC was based on criteria from 
the CDC/NHSN Surveillance Definitions for Specific Types 
of Infections [10]. In this study, we analyzed the inpatient 
data and ambulatory medical records to identify SSIs after 
CSEC procedures. The surveillance protocol and dataset 
were based on the CDC/NHSN criteria. We collected the 
data (demographic and clinical data, microbiology, and 
outcome information from hospital and outpatient records) 
using structured CDC/NHSN Checklist. Cases of SSIs that 
met standard case definitions were identified through ac-
tive follow up during the hospital stay, on return to hospital, 
and during visits to ambulatory. The surveillance period 
for the patients after CSEC was 30 days.
MICROBIOLOGICAL METHODS 
All samples were obtained from women with clinical 
symptoms of SSI. Microbial isolates were identified using 
standard microbiological techniques, including automated 
microbiology testing (Vitek-2; bioMe´rieux, Marcy l’Etoile, 
France). Antibiotic susceptibility testing was performed by 
using the disk diffusion method (Kirby – Bauer antibiotic 
testing) according to the recommendations of the Euro-
pean Committee on Antimicrobial Susceptibility Testing 
(EUCAST). Strains in the intermediate range were classi-
fied as resistant for data analysis. 
ETHICS 
The Shupyk National Healtcare University of Ukraine Eth-
ics Committee approved the waiver of informed consent to 
participate in this study due to its retrospective design. All 
participants data were anonymised prior to the analysis.
STATISTICAL ANALYSIS 
For surgical procedure (CSEC) under surveillance, were 
calculated the percentage of SSIs per 100 operations: an 
indicator which includes both SSIs diagnosed during hos-
pital stay and after discharge from the hospital (detected 
at hospital readmission or by post-discharge surveillance). 
Prevalence of SSIs after CSEC was reported as the per-
centage of the total number of women who had cesarean 
procedure. We analyzed samples from women’s in the 
context of a study about microbiology of SSI after CSEC 
and antimicrobial resistance of responsible pathogens. 
The analysis of statistical data was performed using Excel. 
Comparisons were undertaken using Student’s t-test and 
Fisher’s exact test for categorical variables. Statistical sig-
nificance was defined as P<0.05.
RESULTS 
PREVALENCE OF SSI 
During the study period (2017-2019) applying all meth-
ods of detection, a total of 342 SSIs were identified from 
2326 cesarean procedures. The prevalence of SSI after 
CSEC in Ukraine was 14.7% [95% confidence interval 
Table I. Distribution of surgical site infections after caesarean section in the participating hospitals
Hospital No. of operations No. of SSIs Incidence of SSIs per 100 operations [95% CI]
A 218 29 13.3 [11.0 – 15.6]
B 211 25 11.8 [9.6 – 14.0]
C 203 22 10.8 [8.6 – 13.0]
D 229 56 24.5 [21.7 – 27.3]
E 208 19 9.1 [7.1 – 11.1]
F 212 29 13.7 [11.3 – 16.1]
G 218 31 14.2 [11.8 – 16.4]
H 227 43 18.9 [16.3 – 21.5]
I 193 22 11.4 [9.2 – 13.6]
J 206 27 13.1 [10.8 – 15.4]
K 201 39 19.4 [16.7 – 22.1[
Total 2326 342 14.7 [14.0 – 15.4]
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(CI) 14.0-15.4]. Of these, 152 (44.4%) were superficial 
incisional SSI, 99 (28.9%) were deep incisional SSI, 91 
(26.6%) were organ/space SSI, 25.7% of which were 
classed as endometritis. 
Of all cases 29.5% (101/342) of infections were detected 
in during the admission period and 70.5% (241/342) were 
detected post discharge. The incidence rates of SSI were 
10.7% [95% CI 10.1 – 11.3] after elective cesarean delivery 
Table II. Characteristics of patients with SSI after cesarean delivery in Ukraine (P < 0.05)





≤20 117 13 11.1 10.4 – 11.7
21–25 276 42 15.2 14.5 – 15.9
26–30 417 53 12.7 12.0 – 13.4
31–35 436 57 13.1 12.4 – 13.8
36–40 408 68 16.7 15.9 – 17.5
41–45 261 35 13.4 12.7 – 14.1
46–50 233 41 17.6 16.8 – 17.6
≥51 178 33 18.5 17,7 – 19.3
Total 2326 342 14,7 14.0 – 15.4
Note
aSSI, Surgical site infection
bCI, confidence interval.
Table III. Distribution of microorganisms identified in SSIs following cesarean section in women hospitals (Ukraine, 2017-2019)
Microorganisms All isolates(n=534) Percentages, %
Gram-positive cocci 247 46.3
Staphylococcus aureus 124 23.2
Coagulase-negative staphylococci 43 8.1
Enterococcus species 41 7.7
Streptococcus species 30 5.6
Other Gram-positive cocci 9 1.7
Gram-negative bacilli, Enterobacteriaceae 194 36.3
Escherichia coli 107 20.0
Citrobacter species 7 1.3
Enterobacter species 34 6.4
Klebsiella pneumoniae 19 3.6
Proteus species 16 3.0
Serratia species 4 0.7
Other Enterobacteriaceae 7 1.3
Gram-negative non- fermentative bacilli 73 13.7
Acinetobacter species 21 3.9
Pseudomonas aeruginosa 41 7.7
Stenotrophomonas maltophilia 5 0.9
Other gram-negative non- fermentative bacilli 6 1.1
Anaerobes 15 2.8
Bacteroides species 5 0.9
Other anaerobes 10 1.9
Fungi 5 0.9
Candida species 5 0.9
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and 18% [95% CI 17.2 – 18.8] after urgent cesarean section. 
None of the patients died as a result of SSIs after CSEC 
procedure. The incidence of SSIs after caesarean section 
in the participating hospitals varied significantly (Table I). 
In this study the median time the duration admission 
period for all surgical site infections was 7 days and for 
deep and organ/space infections alone was 9 days. The 
median age of women included in the study was 31 years 
(range 20–51). Сharacteristics of a cohort of women’s had 
cesarean delivery admitted to the regional women’s hos-
pitals of Ukraine are presented in Table II.
ANTIBIOTIC PROPHYLAXIS
In this study 95.9% (2231/2326) of women for whom infor-
mation was collected were given antimicrobial prophylaxis. In 
most hospitals (8/11) the first choice of antibiotic agent was ce-
fazoline or cefotaxim. A further four hospitals used сeftriaxone. 
Of 2326 cesarean delivery participants who underwent chart 
review, 83.7% were prescribed combination ceftriaxone and 
metronidazole postpartum. Ceftriaxone and metronidazole 
was also prescribed for 71.9% participants meeting criteria 
for SSIs, and 28.1% were prescribed alternative antibiotic 
regimens. During the study period, there were two maternal 
deaths in hospitals, none of which were due to infection.
CAUSING PATHOGENS AND ANTIMICROBIAL 
RESISTANCE
A total of 534 different bacterial strains were isolated from 
342 women are with SSIs. Causative microorganisms were 
recorded for all of the infections. Of these infections 56.1% 
(192/342) were reported to be polymicrobial. Aerobic 
gram-negative bacilli make up 50% and 46.3% gram-posi-
tive cocci from of all isolates. The most commonly identifed 
pathogen were Staphylococcus aureus (23.5%), Escherichia 
coli (20%). Other pathogens included Coagulase-negative 
staphylococci (8.1%), Enterococcus spp. (7.7%), Pseudo-
monas aeruginosa (7.7%), Enterobacter spp. (6.4%), and 
Streptococcus spp. (5.6%) as shown in Table III.
In this study among the atibiotics tested, the ertapenem and 
piperacillin/tazobactam, and cefotaxim were the most consis-
tently active against Enterobacteriaceae. The overall proportion 
of extended spectrum beta-lactamase (ESBL) production 
among Enterobacteriaceae was 18.3% and of methicillin-re-
sistance in S. aureus (MRSA) 13.9%. Against P. aeruginosa, the 
carbapenems (meropenem, ertapenem), and trimethroprim/
sulfamethoxazole were the most active agents in infection cas-
es. Vancomycin, teicoplanin, linezolid and fosfomycin, were 
the most consistently active to the strains of Enterococcus spp. 
Resistance to third-generation cephalosporins was observed 
in 15.2% E.coli and 7.9% K. pneumoniae isolates. Carbapenem 
resistance was identified in 7.3% of P.aeruginosa isolates.
DISCUSSION
This study present the first national estimates of the current 
prevalence rate of SSI (incisional and organ / space) after 
CSEC in Ukraine using criteria from the CDC/NHSN 
(USA). The results of SSI surveillance presented in this 
study constitute a useful source of information on SSIs 
following CSEC in the participating women hospitals in 
2017–2019. A total of 2 326 CSEC operations and 14.7% 
SSI were identified within 30 days of the operation. Of 
these, 44.4% were superficial incisional SSI, 28.9% were 
deep incisional SSI, and 26.6% were organ/space SSI. Of 
all cases 70.5% of infections were detected post discharge. 
The incidence of SSI after CSEC is was 7-10% [11-13]. In 
European Union Member States for CSEC operations, the 
percentage of SSIs was 2.2%, with an inter-country range 
from 0.6% to 7.7% [14]. The percentages of SSIs for CSEC 
operations in the Ukraine were significantly higher than 
those reported from EU for 2014–2016 [14] and other 
countries [11-13]. Perhaps this is due to the use of various 
methods for definitions of SSIs and the timing of the post-
operative surveillance period. In the present study, most of 
the patients with SSI were diagnosed after discharge from 
the hospital which is consistent with literature data [15-19].
In the present study, the most frequently identified 
causing pathogens of SSIs following CSEC were S. aureus 
and Escherichia coli, which is consistent with other studies 
[14, 20, 21]. Other pathogens included Coagulase-neg-
ative staphylococci, Enterococcus spp., P. aeruginosa, 
Enterobacter spp., and Streptococcus spp.[21]. The overall 
proportion of extended spectrum beta-lactamase (ESBL) 
production among Enterobacteriaceae was 18.3% and of 
methicillin-resistance in S. aureus (MRSA) 13.9%. Resis-
tance to third-generation cephalosporins was observed 
in 15.2% E.coli and 7.9% Klebsiella pneumoniae isolates. 
Carbapenem resistance was identified in 7.3% of P.aerugi-
nosa isolates. According to literature [22-24] and our local 
antibiotic therapy guidelines, SSIs can be prevented or the 
rates reduced by including appropriate preoperative antibi-
otic prophylaxis. However, despite the use of prophylactic 
antibiotics 14.7% of our patients developed SSI. Perhaps 
this is due to the high level of antimicrobial resistance of 
infectious agents that were identified in our study. 
STRENGTHS AND LIMITATION
The present study is first step is to quantify this burden for 
the first time and estimate of the incidence of SSI following 
CSEC in Ukraine. The strengths of the study lie in the ap-
plication of CDC/NHSN methodology. The diagnosis of SSI 
after CSEC based on the CDC / NHSN criteria and where 
the surveillance period is 30 days. A limitation of the study 
is that it only include 11 (45.8%) from 24 regional women’s 
hospitals in Ukraine. The results this study may not be rep-
resentative of other regional women hospitals of Ukraine 
with different distributions of incidence rate of SSIs after 
CSEC and antimicrobial resistance of causing pathogens. 
CONCLUSIONS
The results of this study revealed high rates of SSI after CSEC 
and most causing pathogens were associated with resistant to 
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antibiotic stranis. The most SSI following CSEC is detected after 
patient’s discharge from the hospital. Urgent cesarean operation 
and improper antibiotic prophylaxis are important risk factors 
in the development of SSI. This knowledge is essential to devel-
op targeted strategies to surveillance and reduce the incidence 
of postoperative infections. Further research is required to 
determine which set of interventions optimize prevetion of SSI 
after CSEC and improvement in patient outcomes.
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